Arkolith/Insider Trading/BIOA/Form 4

Rubin Paul D

Chief Medical OfficerBioAge Labs, Inc. (BIOA) · full profile →Form 4 · filed Apr 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$157K
Net Open-Market Flow
-$157K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2026Option exercise(M)5K$4.11$22K5K
Apr 1, 2026Option exercise(M)3K$6.57$22K9K
Apr 1, 2026Sell(S)9K$17.81$157K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2026Option exercise(M)5K—$00
Apr 1, 2026Option exercise(M)3K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001210905-26-000011) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML